Second-Line Irinotecan, Leucovorin, and 5-Fluorouracil for Gastric Cancer Patients after Failed Docetaxel and S-1
about
The combination of curcumin and 5-fluorouracil in cancer therapy.A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric CancerUpregulation of bone morphogenetic protein 1 is associated with poor prognosis of late-stage gastric Cancer patients.
P2860
Second-Line Irinotecan, Leucovorin, and 5-Fluorouracil for Gastric Cancer Patients after Failed Docetaxel and S-1
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Second-Line Irinotecan, Leucov ...... after Failed Docetaxel and S-1
@ast
Second-Line Irinotecan, Leucov ...... after Failed Docetaxel and S-1
@en
type
label
Second-Line Irinotecan, Leucov ...... after Failed Docetaxel and S-1
@ast
Second-Line Irinotecan, Leucov ...... after Failed Docetaxel and S-1
@en
prefLabel
Second-Line Irinotecan, Leucov ...... after Failed Docetaxel and S-1
@ast
Second-Line Irinotecan, Leucov ...... after Failed Docetaxel and S-1
@en
P2093
P2860
P356
P1476
Second-Line Irinotecan, Leucov ...... after Failed Docetaxel and S-1
@en
P2093
Baek-Yeol Ryoo
Dae Young Zang
Ho Suk Kang
Hong Il Ha
Hunho Song
Hyeong Su Kim
Ji Woong Cho
Joo Young Jung
P2860
P304
P356
10.1155/2016/6857625
P577
2015-12-29T00:00:00Z